Guinness Atkinson Asset Management Inc Purchases 2,550 Shares of Danaher Corporation $DHR

Guinness Atkinson Asset Management Inc grew its position in Danaher Corporation (NYSE:DHR) by 10.0% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 27,930 shares of the conglomerate’s stock after acquiring an additional 2,550 shares during the quarter. Danaher accounts for about 2.9% of Guinness Atkinson Asset Management Inc’s holdings, making the stock its 18th largest position. Guinness Atkinson Asset Management Inc’s holdings in Danaher were worth $5,517,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. Nuveen LLC bought a new position in Danaher in the first quarter worth $833,941,000. Invesco Ltd. raised its stake in shares of Danaher by 44.5% in the 1st quarter. Invesco Ltd. now owns 4,708,578 shares of the conglomerate’s stock valued at $965,259,000 after buying an additional 1,450,703 shares in the last quarter. Baird Financial Group Inc. lifted its holdings in shares of Danaher by 290.6% during the 1st quarter. Baird Financial Group Inc. now owns 1,441,706 shares of the conglomerate’s stock worth $295,550,000 after acquiring an additional 1,072,617 shares during the period. Generation Investment Management LLP boosted its position in shares of Danaher by 33.2% during the 1st quarter. Generation Investment Management LLP now owns 3,178,124 shares of the conglomerate’s stock valued at $651,515,000 after acquiring an additional 791,662 shares in the last quarter. Finally, Parnassus Investments LLC increased its stake in Danaher by 23.3% in the first quarter. Parnassus Investments LLC now owns 3,828,024 shares of the conglomerate’s stock valued at $784,745,000 after acquiring an additional 722,636 shares during the period. 79.05% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have commented on DHR shares. Deutsche Bank Aktiengesellschaft raised their price target on shares of Danaher from $235.00 to $250.00 and gave the stock a “buy” rating in a research note on Wednesday, October 22nd. Cowen reaffirmed a “buy” rating on shares of Danaher in a research note on Wednesday. Robert W. Baird set a $247.00 price objective on Danaher in a research note on Wednesday. TD Cowen lifted their price objective on Danaher from $250.00 to $260.00 and gave the company a “buy” rating in a report on Wednesday, October 22nd. Finally, Royal Bank Of Canada set a $241.00 target price on shares of Danaher in a report on Tuesday, September 2nd. Eighteen equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $243.39.

Insiders Place Their Bets

In other Danaher news, Director Teri List sold 2,778 shares of the company’s stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the transaction, the director owned 20,751 shares of the company’s stock, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 11.20% of the stock is owned by company insiders.

Danaher Stock Performance

Shares of NYSE:DHR opened at $223.03 on Monday. The business has a fifty day moving average of $202.73 and a 200-day moving average of $198.57. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.10 and a current ratio of 1.52. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $258.23. The firm has a market cap of $157.54 billion, a PE ratio of 45.99, a price-to-earnings-growth ratio of 3.41 and a beta of 0.77.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.72 by $0.17. The business had revenue of $6.05 billion for the quarter, compared to the consensus estimate of $6 billion. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The firm’s quarterly revenue was up 4.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.71 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, equities research analysts predict that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be given a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.6%. The ex-dividend date is Friday, September 26th. Danaher’s payout ratio is 26.39%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.